@entity884 caused by beta-hemolytic streptococci is infrequently seen. Members of the @entity166 Society of America's @entity281 ( @entity281 ) were polled for cases of beta-hemolytic @entity883 that were seen between 1 January 1994 and 31 December 1996. Thirty-one cases were submitted by 22 members. The @entity1 ' ages ranged from 4 months to 79 years, and 18 (58.1%) were males. @entity281 occurred in six cases and intravenous drug abuse was noted in only one case. @entity6 was noted in 10 @entity1 (32.3%). Group B beta-hemolytic streptococci accounted for over two-thirds of isolates (21 [67.7%] of 31). Twenty-five @entity1 (80.7%) developed complications of @entity884 , and 15 (48.4%) underwent surgical intervention with valvular revision or excision. Sixty-one percent (19 of 31) received aqueous crystalline @entity3397 either as monotherapy or in combination with @entity801 . In contrast to previously published data, the mortality rate (12.9%) among @entity1 in this survey was remarkably low. There was no infection relapse documented in 16 of the remaining 27 @entity1 for whom posttreatment follow-up information was available.

@entity884 caused by beta-hemolytic streptococci. The XXXX Society of America's @entity281 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity801 :: ('MESH:D005839', 'Chemical') :: ['gentamicin sulfate'] @entity883 :: ('MESH:D013290', 'Disease') :: ['streptococcal endocarditis'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes mellitus'] @entity281 :: ('MESH:D007239', 'Disease') :: ['Prosthetic valve infection', 'EIN', 'Emerging Infections Network'] @entity3397 :: ('MESH:D010400', 'Chemical') :: ['penicillin G'] @entity166 :: ('MESH:D003141', 'Disease') :: ['Infectious Diseases'] @entity884 :: ('MESH:D004696', 'Disease') :: ['Infective endocarditis', 'infective endocarditis']
@entity166 :: (MESH:D003141,Disease) :: ['Infectious Diseases']
